{{Rsnum
|rsid=674210
|Gene=ME2
|Chromosome=18
|position=50920583
|Orientation=minus
|GMAF=0.3191
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ME2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 37.2 | 49.6 | 13.3
| HCB | 41.6 | 42.3 | 16.1
| JPT | 35.4 | 42.5 | 22.1
| YRI | 70.1 | 25.9 | 4.1
| ASW | 56.1 | 36.8 | 7.0
| CHB | 41.6 | 42.3 | 16.1
| CHD | 44.4 | 44.4 | 11.1
| GIH | 60.4 | 34.7 | 5.0
| LWK | 54.5 | 42.7 | 2.7
| MEX | 56.9 | 36.2 | 6.9
| MKK | 60.9 | 32.7 | 6.4
| TSI | 36.3 | 49.0 | 14.7
| HapMapRevision=28
}}{{omim
|id=154270
|desc=MALIC ENZYME 2; ME2
|rsnum=674210
}}

{{omim
|id=154270
|rsnum=674210
|variant=0001
}}

{{PMID Auto
|PMID=15532013
|Title=Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}